CFO of Keryx Biopharmaceuticals Inc. (KERX, Financial) James F Iii Oliviero sells 1,209 shares of KERX on 10/04/2010 at an average price of $4.58 a share.
Keryx Biopharmaceuticals Inc. has a market cap of $275.2 million; its shares were traded at around $4.67 with and P/S ratio of 11.
Keryx Biopharmaceuticals Inc. has a market cap of $275.2 million; its shares were traded at around $4.67 with and P/S ratio of 11.
CFO Recent Trades:
- Sell: CFO James F Oliviero Iii sold 10,000 shares of KERX stock on 08/20/2010 at the average price of 3.84. James F Oliviero Iii owns at least 358,041 shares after this. The price of the stock has increased by 21.61% since.
- Sell: CFO James F Oliviero Iii sold 1,213 shares of KERX stock on 07/06/2010 at the average price of 3.35. James F Oliviero Iii owns at least 368,041 shares after this. The price of the stock has increased by 39.4% since.
- Sell: CFO James F Oliviero Iii sold 41,497 shares of KERX stock on 06/08/2010 at the average price of 3.96. James F Oliviero Iii owns at least 369,254 shares after this. The price of the stock has increased by 17.93% since.
- Sell: CFO James F Oliviero Iii sold 60,000 shares of KERX stock on 05/12/2010 at the average price of 6.26. James F Oliviero Iii owns at least 410,751 shares after this. The price of the stock has decreased by 25.4% since.
Directors and Officers Recent Trades:
- Sell: Director Jack Kaye sold 25,000 shares of KERX stock on 09/29/2010 at the average price of 5.02. Jack Kaye owns at least 161,400 shares after this. The price of the stock has decreased by 6.97% since.
- Sell: 10% Owner Michael S Weiss sold 397,719 shares of KERX stock on 05/10/2010 at the average price of 5.89. Michael S Weiss owns at least 1,320,418 shares after this. The price of the stock has decreased by 20.71% since.
- Sell: 10% Owner Michael S Weiss sold 460,200 shares of KERX stock on 04/13/2010 at the average price of 3.81. Michael S Weiss owns at least 1,948,067 shares after this. The price of the stock has increased by 22.57% since.
